1,1,1,3,3-Pentakis(dimethylamino)-3-(methylimino)-1λ⁵,3λ⁵-diphosphazene | 111324-00-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1,1,1,3,3-Pentakis(dimethylamino)-3-(methylimino)-1λ⁵,3λ⁵-diphosphazene
• 英文别名: N-[dimethylamino-methylimino-[[tris(dimethylamino)-lambda5-phosphanylidene]amino]-lambda5-phosphanyl]-N-methylmethanamine；N-[dimethylamino-methylimino-[[tris(dimethylamino)-λ5-phosphanylidene]amino]-λ5-phosphanyl]-N-methylmethanamine
• CAS: 111324-00-6
• 化学式: C₁₁H₃₃N₇P₂
• 分子量: 325.377
• InChiKey: PGJVVZGZMUXWDW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  亚氨基-三(二甲氨基)正膦 在 KSC₁₂H₂₅ 作用下， 以 乙腈 为溶剂， 反应 182.0h， 生成 1,1,1,3,3-Pentakis(dimethylamino)-3-(methylimino)-1λ⁵,3λ⁵-diphosphazene
  参考文献：
  名称：

  Schwesinger, Reinhard; Schlemper, Helmut, Angewandte Chemie, 1987, vol. 99, # 11, p. 1212 - 1214

  摘要：

  DOI：

文献信息

• Process for producing fluorinated isocyanates and carbamates
  申请人：REPSOL YPF S.A.

  公开号：EP2036884A1

  公开（公告）日：2009-03-18

  The invention relates to a process for producing fluorinated carbamates comprising the reaction between an amine or polyamine and a fluorinated carbonate, in the presence of a catalyst which does not contain metals and comprises at least one tertiary amine group. The process can also comprise an additional step in which the carbamates are transformed into the corresponding isocyanates.

  该发明涉及一种生产氟化碳酸酯的方法，包括胺或多胺与氟化碳酸酯在不含金属的催化剂存在下反应，所述催化剂至少包含一个三级胺基团。该方法还可以包括一个额外步骤，将碳酸酯转化为相应的异氰酸酯。
• CURABLE-ON-DEMAND COMPOSITION COMPRISING DUAL REACTIVE SILANE FUNCTIONALITY
  申请人：Yang Yu

  公开号：US20130178553A1

  公开（公告）日：2013-07-11

  A curable composition comprises (a) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydrosilyl moiety; (b) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydroxysilyl moiety, the hydroxysilyl moiety optionally being generated in situ by hydrolysis of at least one hydrosilyl moiety; and (c) at least one photoactivatable composition that, upon exposure to radiation, generates at least one base selected from amidines, guanidines, phosphazenes, proazaphosphatranes, and combinations thereof; with the proviso that, when component (a) is an organic polymer, then component (b) is different from component (a) and is not generated in situ by hydrolysis of component (a).

  一种可治愈的组合物包括：（a）至少一种含有反应性硅烷官能团的无机或有机化合物，其中硅烷官能团包括至少一个氢硅烷基；（b）至少一种含有反应性硅烷官能团的无机或有机化合物，其中硅烷官能团包括至少一个羟基硅烷基，羟基硅烷基可以通过至少一个氢硅烷基的水解而在原位生成；以及（c）至少一种光活性组合物，当暴露于辐射下时，生成至少一种从氨基甲酸酰胺、鸟嘌呤、磷氮烷、丙氨酸磷酸酯和其组合物中选择的碱，前提是当组分（a）是有机聚合物时，组分（b）与组分（a）不同，并且不是通过组分（a）的水解在原位生成的。
• CURABLE-ON-DEMAND POLYSILOXANE COATING COMPOSITION
  申请人：Yang Yu

  公开号：US20130101841A1

  公开（公告）日：2013-04-25

  A curable composition comprises (a) at least one polydiorganosiloxane, fluorinated polydiorganosiloxane, or combination thereof comprising reactive silane functionality comprising at least two hydroxysilyl moieties; (b) at least one polydiorganosiloxane, fluorinated polydiorganosiloxane, or combination thereof comprising reactive silane functionality comprising at least two hydrosilyl moieties; and (c) at least one photoactivatable composition that, upon exposure to radiation, generates at least one base selected from amidines, guanidines, phosphazenes, proazaphosphatranes, and combinations thereof; wherein at least one of the components (a) and (b) has an average reactive silane functionality of at least three.

  可治疗组合物包括：(a)至少一种聚二甲基硅氧烷、氟代聚二甲基硅氧烷或二者的组合物，其包含具有至少两个羟基硅基的反应性硅烷官能团；(b)至少一种聚二甲基硅氧烷、氟代聚二甲基硅氧烷或二者的组合物，其包含具有至少两个氢硅基的反应性硅烷官能团；以及(c)至少一种光致活性组分，当暴露于辐射下时，会产生从氨基化合物、胍化合物、磷氮化合物、脲基磷杂环丙烷和它们的组合物中选择的至少一种碱；其中，组分(a)和/或(b)中至少有一种的平均反应性硅烷官能团为至少三个。
• CURABLE COMPOSITION COMPRISING DUAL REACTIVE SILANE FUNCTIONALITY
  申请人：Yang Yu

  公开号：US20130102728A1

  公开（公告）日：2013-04-25

  A curable composition comprises (a) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydrosilyl moiety; (b) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydroxysilyl moiety, the hydroxysilyl moiety optionally being generated in situ by hydrolysis of at least one hydrosilyl moiety; and (c) at least one base selected from amidines, guanidines, phosphazenes, proazaphosphatranes, and combinations thereof; with the proviso that, when component (a) is an organic polymer, then component (b) is different from component (a) and is not generated in situ by hydrolysis of component (a).

  一种可治愈的组合物包括：（a）至少一种含有反应性硅烷官能团的无机或有机化合物，其中该反应性硅烷官能团包括至少一个氢硅烷基；（b）至少一种含有反应性硅烷官能团的无机或有机化合物，其中该反应性硅烷官能团包括至少一个羟基硅烷基，该羟基硅烷基可以通过至少一个氢硅烷基的水解而在原位生成；以及（c）选自氨基甲酸酰胺、鸟氨酸、磷氮化物、丙磺酰膦杂环戊烷和其组合物中的至少一种碱，但当组分（a）为有机聚合物时，则组分（b）与组分（a）不同且不是通过组分（a）的水解在原位生成的。
• Schwesinger, Reinhard; Schlemper, Helmut; Hasenfratz, Christian, Liebigs Annalen, 1996, # 7, p. 1055 - 1081
  作者：Schwesinger, Reinhard、Schlemper, Helmut、Hasenfratz, Christian、Willaredt, Juergen、Dambacher, Tim、Breuer, Thomas、Ottaway, Carol、Fletschinger, Michael、Boele, Joachim、Fritz, Hans、Putzas, Dietmar、Rotter, Heinz W.、Bordwell, Frederick G.、Satish, Amruthur V.、Ji, Guo-Zen、Peters, Eva-Maria、Peters, Karl、Von Schnering, Hans Georg、Walz, Leonhard

  DOI：——

  日期：——